Mackenzie Financial’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-209,031
| Closed | -$151K | – | 1776 |
|
|
2025
Q1 | $151K | Buy |
209,031
+21,472
| +11% | +$15.5K | ﹤0.01% | 1554 |
|
|
2024
Q4 | $193K | Buy |
187,559
+155,656
| +488% | +$160K | ﹤0.01% | 1569 |
|
|
2024
Q3 | $42.8K | Sell |
31,903
-826
| -3% | -$1.11K | ﹤0.01% | 1544 |
|
|
2024
Q2 | $42.5K | Buy |
32,729
+4,287
| +15% | +$5.57K | ﹤0.01% | 1500 |
|
|
2024
Q1 | $48.9K | Buy |
28,442
+6,980
| +33% | +$12K | ﹤0.01% | 1481 |
|
|
2023
Q4 | $31.5K | Buy |
21,462
+4,264
| +25% | +$6.27K | ﹤0.01% | 1471 |
|
|
2023
Q3 | $20.1K | Hold |
17,198
| – | – | ﹤0.01% | 1451 |
|
|
2023
Q2 | $25.3K | Buy |
+17,198
| New | +$25.3K | ﹤0.01% | 1490 |
|